Concurrent effects of ABCB1 C3435T, ABCG2 C421A, and XRCC1 Arg194Trp genetic polymorphisms with risk of cancer, clinical output, and response to treatment with imatinib mesylate in patients with chronic myeloid leukemia
Crossref DOI link: https://doi.org/10.1007/s13277-015-3874-4
Published Online: 2015-08-07
Published Print: 2016-01
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Salimizand, Hana
Amini, Sabrieh
Abdi, Mohammad
Ghaderi, Bayazid
Azadi, Namam-Ali
Text and Data Mining valid from 2015-08-07